Found: 1
Select item for more details and to access through your institution.
A phase I study of TRC105 anti-endoglin ( CD105) antibody in metastatic castration-resistant prostate cancer.
- Published in:
- BJU International, 2015, v. 116, n. 4, p. 546, doi. 10.1111/bju.12986
- By:
- Publication type:
- Article